MAMK vs RNA

Comparison between MaxsMaking Inc - Class A (MAMK, Company) and Atrium Therapeutics Inc (RNA, Company).

MAMK is from the Industrials sector, while RNA is from the Healthcare sector.

MAMK vs RNA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MAMK(COMPANY)	RNA(COMPANY)
Market Cap	$216M	$217M
Max Drawdown	46.61%	30.17%
Sharpe Ratio	1.58	-0.87
5Y Beta	-0.11	0.99
Industry	Conglomerates	Biotechnology
P/E Ratio	109081.93	N/A
Debt to Equity	35.21%	0.00%
Free Cash Flow Yield	-2.47%	0.00%

Market Cap

MAMK

$216M

Winner

RNA

$217M

Max Drawdown

MAMK

46.61%

Winner

RNA

30.17%

Sharpe Ratio

Winner

MAMK

1.58

RNA

-0.87

5Y Beta

Winner

MAMK

-0.11

RNA

0.99

Industry

MAMK

Conglomerates

RNA

Biotechnology

P/E Ratio

MAMK

109081.93

RNA

N/A

Debt to Equity

MAMK

35.21%

Winner

RNA

0.00%

Free Cash Flow Yield

MAMK

-2.47%

Winner

RNA

0.00%

MAMK vs RNA - Historical Returns

Returns include dividend reinvestment.

Period	MAMK	RNA
1 month	+0.00%	-2.24%
3 months	+0.00%	+2.76%
6 months	+0.00%	N/A
1 year	+252.30%	N/A
Max(CAGR)	+277.87%	-39.52%

Winner

MAMK

+0.00%

RNA

-2.24%

MAMK

+0.00%

Winner

RNA

+2.76%

MAMK

+0.00%

RNA

N/A

MAMK

+252.30%

RNA

N/A

Max(CAGR)

Winner

MAMK

+277.87%

RNA

-39.52%

MAMK vs RNA - Annual Returns (2025 - 2026)

Returns include dividend reinvestment.

Year	MAMK	RNA
2026	+0.00%	-14.17%
2025	+252.30%	N/A

MAMK vs RNA Drawdown Comparison

The maximum drawdown for MAMK was -46.61%, occurring on Aug 13, 2025. Recovery took 78 trading sessions.

The maximum drawdown for RNA was -30.17%, occurring on Jun 8, 2026. This drawdown has not yet recovered.

The current MAMK drawdown is -4.62%. The current RNA drawdown is -23.46%.

Rank	MAMK	RNA
#1	-46.61% Jul 7, 2025 - Oct 24, 2025	-30.17% Mar 4, 2026 - Jun 8, 2026
#2	-34.97% Oct 24, 2025 - Nov 3, 2025	N/A
#3	-5.93% Nov 7, 2025 - Nov 11, 2025	N/A
#4	-4.62% Nov 12, 2025 - Nov 14, 2025	N/A